-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_executive.pdf
March 01, 2011 - new studies were generally of short duration (less than
1 year) and had few long-term events (such as deaths … We recommend that studies consistently report the
number of deaths in each study arm, even if there
were … Low Many RCTs were of short duration (less than 1 year) and had few deaths, limiting
the precision of
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_surveillance.pdf
December 01, 2012 - period: The original CER did not provide any data on Symptomatic VTE,
Symptomatic non-fatal PE, and deaths … 1,001 (0.1) in dabigatran group versus 2/992 (0.2) in enoxaparin group; p-value=0.62. 7
No Signal
• Deaths … . 7 No Signal
During follow up: The original CER did not provide any data on symptomatic VTE, and deaths
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guide-editorial_methods.pdf
July 01, 2012 - Methods Guide for Medical Test Reviews - Editorial
E-1
Editorial
Methods Guide for Authors of Systematic Reviews
of Medical Tests:
A Collaboration Between the Agency for Healthcare
Research and Quality (AHRQ) and the Journal
of General Internal Medicine
Gerald W. Smetana, M.D., Beth Israel Deaconess…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-safety-practices_research-protocol.pdf
November 09, 2011 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: November 9, 2011
Evidence-based Practice Center Systematic Review Protocol
Project Title: Critical Analysis of the Evidence for Patient Safety Practices
I. Background and Objectives fo…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy_research-protocol.pdf
September 14, 2016 - The Role of Immunotherapy and the Management of Asthma: Systematic Review
Source: www.effectivehealthcare.ahrq.gov
Published online: September 14, 2016
Evidence-based Practice Center Systematic Review Protocol
Project Title: The Role of Immunotherapy and the Management of Asthma:
Systematic Review …
-
effectivehealthcare.ahrq.gov/sites/default/files/decide16final-mortality-risk-in-copd-pts-using-theophylline.pdf
December 01, 2009 - Unadjusted Outcomes by Treatment Group
Deaths Exacerbationsa Hospitalizationsa
N (%) HR (95% CI
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-management_research.pdf
December 01, 2009 - Unadjusted Outcomes by Treatment Group
Deaths Exacerbationsa Hospitalizationsa
N (%) HR (95% CI
-
effectivehealthcare.ahrq.gov/sites/default/files/schwitzer_eccs2012.pdf
July 23, 2012 - Mount Sinai School of Medicine in [New York],
said he thinks the new guidelines could cause unnecessary deaths
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-anticholinergic-medicines_research.pdf
December 01, 2009 - time bias
into the analysis.20-22
Effective Health Care Research Report Number 15
3
Deaths … were identified using the VA Vital Status file, which captures
approximately 98% of deaths.23 Exacerbations
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-stenting_research-protocol.pdf
August 19, 2011 - disease (CAD) is a leading cause of morbidity and mortality worldwide,
accounting for 35 percent of all deaths … in the United States and 30 percent of all deaths globally
in 2005.1 The diagnosis of CAD is made on
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-disposition-comments.pdf
November 07, 2023 - potential benefits because
we want to look for
evidence regarding
whether the treatments
would reduce deaths … it could be a
harm – e.g., if a
medication has some
severe adverse event that
could lead to more deaths … mortality data, we must
always have an open mind
about what the data is
showing (were there more
deaths … or fewer deaths in
the medication group than
in the placebo group?)
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
January 01, 2007 - Layout 1
Background
Type 2 diabetes is characterized by insulin
resistance accompanied by progressive
deficiency in insulin secretion. Type 2
diabetes is an increasingly common disease
that is closely associated with obesity. In
2005, the prevalence of Americans with
diagnosed type 2 diabetes was 2.4 percent
for ad…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_disposition-comments.pdf
December 30, 2015 - in every controlled trial (even if
there are no deaths): see Iannidis, Evans, Gotzsche,
...CONSORT … Does the strategy of this
review ignore deaths because no patient self-reported his
own death? … There were indeed deaths in these studies,
e.g., Ancoli-Israel et al., reference 108, which are not … We described specific adverse effects including
deaths in the text. … We have added any information on deaths and other
serious adverse events from Ancoli-Israel and other
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_disposition-comments.pdf
October 07, 2011 - For example, angioedema is important, but how many deaths
attributable to it can actually be found yearly
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_appendixes.pdf
October 06, 2006 - E-10
Appendix E: Abstraction Forms (continued)
οSurvival free from cardiovascular deaths
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-dietary-digestible-executive-summary.pdf
March 01, 2025 - Recent trends in cardiovascular disease
deaths: a state specific perspective.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_disposition-comments.pdf
November 27, 2012 - with a 0.5%
perioperative mortality (the
largest series of patients with
HCV infection found no deaths … “HCV infection… associated with an estimated 12,000 deaths each
year in the United States.” … The largest study of HCV
patients showed no deaths. … Mortality is 12,000 deaths per year. … in 2010 could reduce the risk of
cirrhosis, liver decompensation, liver cancer, and liver related deaths
-
effectivehealthcare.ahrq.gov/sites/default/files/reporting.ppt
September 01, 2009 - There were no deaths reported in the three respiratory syncytial virus/severe bronchiolitis trials; thus … than PSA [prostate-specific antigen] testing and treated with radical prostatectomy experienced fewer deaths … from prostate cancer, marginally fewer deaths from any cause, and fewer distant metastases.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-screening_research-protocol.pdf
May 18, 2011 - More
than 50,000 deaths from CRC are expected to have occurred in 2010, representing 9 percent of … all the cancer deaths in the United States.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-selection-harms-systematic-reviews.pdf
February 01, 2018 - Prioritization and Selection of Harms for Inclusion in Systematic Reviews
Prioritization and Selection of Harms
for Inclusion in Systematic Reviews
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Systematic Reviews Methods Guide
www.ahrq.gov
Presenter
Presentation Notes
P…